LICENSE AND OPTION AGREEMENTLicense and Option Agreement • November 4th, 2009 • Cornerstone Therapeutics Inc • Pharmaceutical preparations • California
THIS LICENSE AND OPTION AGREEMENT (the “Agreement”) is made this 22nd day of October, 2002 (the “Effective Date”) by and between GENESOFT PHARMACEUTICALS, INC., a Delaware corporation having its principal place of business at 7300 Shoreline Court, South San Francisco, CA, USA 94080 (“GS”) and LG LIFE SCIENCES, LTD., a corporation organized under the laws of the Republic of Korea having its principal place of business at LG Twin Tower, 20 yoido-dong, Youngdungpo-gu, Seoul, 150-721, Republic of Korea (“LGLS”). LGLS and GS are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
WAKE COUNTY LEASE MODIFICATION AGREEMENT NO. 2Lease Modification Agreement • November 4th, 2009 • Cornerstone Therapeutics Inc • Pharmaceutical preparations
THIS LEASE MODIFICATION AGREEMENT NO. 2 (this “Amendment”) is made and entered into as of this 2nd day of October, 2009 (the “Amendment Execution Date”), by and between Crescent Lakeside, LLC, a North Carolina limited liability company (“Landlord”), and Cornerstone Therapeutics Inc., a Delaware corporation authorized to conduct business in the State of North Carolina (“Tenant”) and successor by assignment from Cornerstone BioPharma Holdings, Inc.
SECOND AMENDMENT TO AMENDED AND RESTATED RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • November 4th, 2009 • Cornerstone Therapeutics Inc • Pharmaceutical preparations
This SECOND AMENDMENT TO AMENDED AND RESTATED RESTRICTED STOCK AGREEMENT (this “Amendment”) is made and entered into as of the 27th day of July, 2009 (the “Amendment Date”), by and between Cornerstone BioPharma Holdings, Inc., a Delaware corporation (the “Company”), and David Price (the “Participant”). Capitalized terms used herein that are not otherwise defined herein shall have the meanings given to them in the Restricted Stock Agreement (as defined below) or the Company’s 2005 Stock Incentive Plan (the “Plan”), as applicable.
STATE OF NORTH CAROLINA WAKE COUNTYLease Modification Agreement No. 1 • November 4th, 2009 • Cornerstone Therapeutics Inc • Pharmaceutical preparations
THIS LEASE MODIFICATION AGREEMENT NO. 1 (this “Agreement”) is made and entered into as of this 31st day of October, 2008 (the “Execution Date”), by and between Crescent Lakeside, LLC, a North Carolina limited liability company (“Landlord”), and Cornerstone BioPharma Holdings, Inc., a Delaware corporation authorized to conduct business in the State of North Carolina (“Tenant”).
